QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Philip Gavuzzi joins Quantify!
Today we are happy to introduce Philip Gavuzzi who joined the Stockholm team as a Research Analyst last week. Philip has a background in economic analysis and hold a master’s in economics from Linköping University. He has previously worked within the financial sector as an AML-analyst but is now looking forward to exploring new areas at Quantify.
[…]
Ethan O’Leary joins Quantify!
Today we are delighted to introduce Ethan O’Leary who joined our Stockholm team as a Research Analyst this Monday!
Ethan is currently finishing his Master’s in Economics from Stockholm School of Economics (SSE) and carries research and consulting experience in econometric modeling. Ethan’s past research has focused on inequality and social cues of individual behavior. […]
Quantify’s Christoph Abé published and featured on the cover of renowned Biological Psychiatry
Quantify’s Christoph Abé (PhD) publishes the largest-ever study associating bipolar disorder with abnormal brain changes over time in the renowned journal Biological Psychiatry, using neuroimaging data.
—
Our Lead Analyst, Christoph Abé (PhD) led an international multi-center neuroimaging study on bipolar disorder showing that the disorder is associated with abnormal brain changes over time. The largest longitudinal brain imaging study in its field is now […]
A new conceptual framework in psoriasis
Check out this recent publication from Quantify, presenting a new conceptual framework in psoriasis that differentiates psoriasis severity from disease control (Link to article: https://onlinelibrary.wiley.com/doi/10.1111/bjd.21023https://lnkd.in/gJtZtENB). Authored by Quantify’s CEO Kirk Geale, this article published in the British Journal of Dermatology is a step forward in modernizing the way we view psoriasis within today’s treatment paradigm. We hope this new approach […]